In the BioHarmony Drug Report Database
Mirtazapine
Remeron, Remeron Soltab (mirtazapine) is a small molecule pharmaceutical. Mirtazapine was first approved as Remeron on 1996-06-14. It is used to treat depressive disorder in the USA. The pharmaceutical is active against alpha-2B adrenergic receptor, 5-hydroxytryptamine receptor 2C, alpha-2C adrenergic receptor, 5-hydroxytryptamine receptor 2A, and alpha-2A adrenergic receptor.
Trade Name
|
Remeron, Remeron Soltab |
|---|---|
Common Name
|
mirtazapine |
ChEMBL ID
|
CHEMBL654 |
Indication
|
depressive disorder |
Drug Class
|
Tricyclic compounds |
Image (chem structure or protein)